Acute Myeloid Leukemia with LRRFIP1::FGFR1 Rearrangement and a Complex Karyotype

[1]  A. Bagg,et al.  Pemigatinib for the treatment of myeloid/lymphoid neoplasms with FGFR1 rearrangement , 2023, Expert review of anticancer therapy.

[2]  B. Ebert,et al.  Diagnosis and Management of AML in Adults: 2022 ELN Recommendations from an International Expert Panel. , 2022, Blood.

[3]  M. Loh,et al.  International Consensus Classification of Myeloid Neoplasms and Acute Leukemia: Integrating Morphological, Clinical, and Genomic Data. , 2022, Blood.

[4]  Y. Natkunam,et al.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms , 2022, Leukemia.

[5]  J. Gotlib,et al.  World Health Organization‐defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management , 2022 .

[6]  L. Rimsza,et al.  Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2. , 2020, American journal of clinical pathology.

[7]  M. Arcila,et al.  FGFR1 Rearrangement Guides Diagnosis and Treatment of a Trilineage B, T, and Myeloid Mixed Phenotype Acute Leukemia. , 2020, JCO precision oncology.

[8]  L. Cavelier,et al.  Detection of leukemia gene fusions by targeted RNA-sequencing in routine diagnostics , 2020, BMC Medical Genomics.

[9]  D. Arber,et al.  Prognostic Significance of Complex Karyotypes in Acute Myeloid Leukemia , 2019, Current Treatment Options in Oncology.

[10]  E. Arranz,et al.  A Case of Myeloproliferative Neoplasm with BCR-FGFR1 Rearrangement: Favorable Outcome after Haploidentical Allogeneic Transplantation , 2018, Case reports in hematology.

[11]  A. Takaori-Kondo,et al.  Allogeneic hematopoietic stem cell transplantation for 8p11 myeloproliferative syndrome with BCR-FGFR1 gene rearrangement: a case report and literature review , 2018, Bone Marrow Transplantation.

[12]  V. Najfeld,et al.  Myeloid/lymphoid neoplasms with FGFR1 rearrangement , 2018, Leukemia & lymphoma.

[13]  S. Fujiwara,et al.  Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement , 2018, Hematology.

[14]  L. Medeiros,et al.  Hematolymphoid neoplasms associated with rearrangements of PDGFRA, PDGFRB, and FGFR1. , 2015, American journal of clinical pathology.

[15]  Yonggoo Kim,et al.  Acute myeloid leukemia associated with FGFR1 abnormalities , 2013, International Journal of Hematology.

[16]  A. Tefferi,et al.  Chromosome 8p11.2 translocations: Prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution , 2010, American journal of hematology.

[17]  S. Romana,et al.  LRRFIP1, a new FGFR1 partner gene associated with 8p11 myeloproliferative syndrome , 2009, Leukemia.

[18]  R. Aguiar,et al.  A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review. , 1995, Leukemia.